Axentri 150mg Tablet
Introduction to Axentri 150mg Tablet
Axentri 150mg Tablet is a medication used to treat a specific type of HIV infection known as CCR5-tropic HIV-1. It is typically prescribed in combination with other antiretroviral drugs to help manage HIV and reduce the risk of developing AIDS and related illnesses.
Composition of Axentri 150mg Tablet
The active ingredient in Axentri 150mg Tablet is Maraviroc. This component plays a crucial role in preventing the HIV virus from entering and infecting immune cells.
Uses of Axentri 150mg Tablet
- Treats CCR5-tropic HIV-1 infection in adults and children weighing at least 2 kg.
- Used in combination with other antiretroviral medications.
- Helps manage HIV infection and reduce the risk of developing AIDS.
Side effects of Axentri 150mg Tablet
Common side effects:
- Cough
- Runny nose
- Dizziness
- Diarrhea
- Constipation
Serious side effects:
- Hepatotoxicity (liver damage)
- Severe skin reactions
- Cardiovascular events
Precautions of Axentri 150mg Tablet
Before taking Axentri 150mg Tablet, inform your healthcare provider if you have any liver issues or severe renal impairment. It is important to monitor liver function and watch for signs of allergic reactions. Avoid using this medication if you have severe renal impairment and are taking potent CYP3A inhibitors or inducers.
How to Take Axentri 150mg Tablet
- Take the tablet as prescribed by your healthcare provider.
- It can be taken with or without food.
- For adults, the usual dose is 150 mg, 300 mg, or 600 mg twice daily, depending on other medications being taken.
- For children weighing at least 2 kg, the dose is based on body weight and other medications.
Conclusion of Axentri 150mg Tablet
Axentri 150mg Tablet is an effective medication for managing CCR5-tropic HIV-1 infection when used in combination with other antiretroviral drugs. It is important to follow your healthcare provider's instructions and report any severe side effects immediately. Regular monitoring and adherence to prescribed dosages can help maintain your health and manage HIV effectively.
More medicines by Emcure Pharmaceuticals Ltd
L-Ornithine L-Aspartate (500mg)
Domperidone (30mg) + Esomeprazole (40mg)
Tigecycline (50mg)
L-Ornithine L-Aspartate (150mg)
Fosphenytoin (150mg)
Related Faqs
Can I breastfeed while receiving treatment with Tenvir for chronic HBV infection?
No, you should not breastfeed your baby since small amounts of Tenvir pass into breast milk. Further, if your baby does not have HIV or HBV, there is a chance that the baby can get HIV or HBV through breastfeeding.
I vomited after taking Tafnat. What should I do?
If vomiting occurs within 1 hour of taking Tafnat then you should take another tablet. However, if you vomit after more than an hour of taking Tafnat then you need not take another tablet. Consult your doctor if you have vomiting every time you take Tafnat or if the vomiting persists for a longer duration.
I vomited after taking Tafsure. What should I do?
If vomiting occurs within 1 hour of taking Tafsure then you should take another tablet. However, if you vomit after more than an hour of taking Tafsure then you need not take another tablet. Consult your doctor if you have vomiting every time you take Tafsure or if the vomiting persists for a longer duration.
What is drug resistance? Can I develop drug resistance with Hepalo?
Drug resistance is a state where the medicine which was once effective in treating an infection becomes ineffective. This mainly happens due to the ability acquired by the virus or bacteria to get modified inside the body which affects the overall working of the medicine. Hence, the medicine is no longer able to fight against the virus or bacteria. Generally, drug resistance with Hepalo is more likely to happen if you take less dose than what is recommended.
What if HIV infection co-exists with HBV infection? Will this affect treatment with Hivir?
In HBV patients who are diagnosed with HIV, Hivir is not recommended until and unless these patients start taking medicines for HIV management. Starting Hivir in such patients may cause resistance to the prescribed HIV medicines. Therefore, doctors recommend tests for HIV in patients diagnosed with HBV infection before starting treatment with Hivir.
What if HIV infection co-exists with HBV infection? Will this affect treatment with Lamidac?
In HBV patients who are diagnosed with HIV, Lamidac is not recommended until and unless these patients start taking medicines for HIV management. Starting Lamidac in such patients may cause resistance to the prescribed HIV medicines. Therefore, doctors recommend tests for HIV in patients diagnosed with HBV infection before starting treatment with Lamidac.
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
Axentri 150mg Tablet
Prescription Required
Packaging :
strip of 10 tablets
Manufacturer :
Emcure Pharmaceuticals LtdComposition :
Maraviroc (150mg)
.svg)
